Seretide Accuhaler 50/250 mcg Inhalation Powder

Seretide Accuhaler 50/250 Mcg Inhalation Powder

The Seretide Accuhaler 50/250 Mcg Inhalation Powder is a combination medication used for the management of asthma and chronic obstructive pulmonary disease (COPD). It contains fluticasone propionate, a corticosteroid, and salmeterol, a long-acting beta-2 agonist, which work together to reduce inflammation and relax the muscles in the airways, making breathing easier.

• Combination of fluticasone propionate and salmeterol
• Used for asthma and COPD management
• Reduces inflammation and relaxes airway muscles

• Strength 50 mcg salmeterol and 250 mcg fluticasone propionate
• Form Inhalation powder

Ideal for patients with asthma or COPD who require regular treatment to manage symptoms and improve breathing.

Suitable for adults and adolescents aged 12 years and older with asthma or COPD.

Seretide is a brand of GlaxoSmithKline, a leading pharmaceutical company known for its innovative treatments in respiratory care. GSK has pioneered several therapeutic solutions in the field, making it a trusted name in respiratory health.